Use of Volsurf approach for pharmacokinetic optimization of β-carboline derivatives as antitumor agents
Subject Areas : Journal of the Iranian Chemical Research
Jahan B.Ghasemi
1
(Chemistry Department, Faculty of Science, K.N. Toosi University of Technology, Tehran, Iran)
Valentin Davoudian
2
(Chemistry Department, Faculty of Science, K.N. Toosi University of Technology, Tehran, Iran)
Keywords:
Abstract :
[1] J. Cheng, K.R. Mitchelson, J Chromatogr A 761 (1997) 297-305.
[2] M. Kartal, M. Altun, S. Kurucu, J. Pharm. Biomed. Anal. 31 (2003) 263-269.
[3] Y. Iinuma, S. Kozawa, H. Ishiyama, M. Tsuda, E. Fukushi, J. Kawabata, J. Fromont, Jun'ichi Kobayashi,
J. Nat. Prod. 68 (2005) 1109-1110.
[4] A.S. Nazari Formagio, P.R. Santos, K. Zanoli, T. Ueda-Nakamura, L.T. Dusman Tonin, C.V. Nakamura,
M.H. Sarragiotto, Eur. J. Med. Chem. 44 (2009) 4695-4701.
[5] W. Schlecker, A. Huth, E. Ottow, J. Mulzer, Synthesis 1995 (1995) 1225-1227.
[6] N. Lin, M. Zhao, C. Wang, S. Peng, Bioorg. Med. Chem. Lett. 12 (2002) 585-587.
[7] C. Di Giorgio, F. Delmas, E. Ollivier, R. Elias, G. Balansard, P. Timon-David, Exp. Parasitol. 106 (2004)
67-74.
[8] M.A. Collins, Parkinsonism Relat. D 8 (2002) 417-422.
[9] S.P. Hollinshead, M.L. Trudell, P. Skolnick, J.M. Cook, J. Med. Chem. 33 (1990) 1062-1069.
[10] B. Grella, M. Teitler, C. Smith, K. Herrick-Davis, R. Glennon, Bioorg. Med. Chem. Lett. 13 (2003)
4421-4425.
[11] R.A. Glennon, B. Grella, R.J. Tyacke, A. Lau, J. Westaway, A.L. Hudson, Bioorg. Med. Chem. Lett. 14
(2004) 999-1002.
[12] A.F.M. Abdel-Fattah, K. Matsumoto, H.A.K. Gammaz, H. Watanabe, Pharmacol. Biochem. Behav. 52
(1995) 421-426.
[13] J. Ishida, H.K. Wang, K.F. Bastow, C.Q. Hu, K.H. Lee, Bioorg. Med. Chem. Lett. 9 (1999) 3319-3324.
[14] M. Zhao, L. Bi, W. Wang, C. Wang, M. Baudy-Floc'h, J. Ju, S. Peng, Bioorg. Med. Chem. 14 (2006)
6998-7010.
[15] R. Cao, W. Peng, H. Chen, X. Hou, H. Guan, Q. Chen, Y. Ma, A. Xu, Eur. J. Med. Chem. 40 (2005)
249-257.
[16] R. Cao, Q. Chen, X. Hou, H. Chen, H. Guan, Y. Ma, W. Peng, A. Xu, Bioorg. Med. Chem. 12 (2004)
4613-4623.
[17] Q. Wu, R. Cao, M. Feng, X. Guan, C. Ma, J. Liu, H. Song, W. Peng, Eur. J. Med. Chem. 44 (2009) 533-
540.
[18] H. Guan, H. Chen, W. Peng, Y. Ma, R. Cao, X. Liu, A. Xu, Eur. J. Med. Chem. 41 (2006) 1167-1179.
J. Ghasemi & V. Davoudian, J. Iranian Chem. Res. 5 (1) (2012) 47-54
54
[19] M.R. Doddareddy, J.H. Cha, Y.S. Cho, H.Y. Koh, K.H. Yoo, D.J. Kim, A.N. Pae, Bioorg. Med. Chem.
13 (2005) 3339-3349.
[20] P. Crivori, B. Reinach, D. Pezzetta, I. Poggesi, Mol. Pharmaceut. 3 (2006) 33-44.
[21] R. Cao, X. Guan, B. Shi, Z. Chen, Z. Ren, W. Peng, H. Song, Eur. J. Med. Chem. 45 (2010) 2503-2515.
[22] B.D. Hudson, R.M. Hyde, E. Rahr, J. Wood, J. Osman, Quantitative Structure-Activity Relationships 15
(1996) 285-289.
[23] G. Cruciani, P. Crivori, P.A. Carrupt, B. Testa, J. Mol. Struct. (THEOCHEM) 503 (2000) 17-30.
[24] P. Crivori, G. Cruciani, P.A. Carrupt, B. Testa, J. Med. Chem. 43 (2000) 2204-2216.
[25] I. Zamora, T. Oprea, G. Cruciani, M. Pastor, A.L. Ungell, J. Med. Chem. 46 (2003) 25-33.
[26] J. Boccard, F. Bajot, A. Di Pietro, S. Rudaz, A. Boumendjel, E. Nicolle, P.A. Carrupt, Eur. J. Pharm.
Sci. 36 (2009) 254-264.
[27] R. Leardi, A. Lupianez Gonzalez, Chemometr. Intell. Lab. Syst. 41 (1998) 195-207.
